Literature DB >> 25806144

Automatic Segmentation of Polypoidal Choroidal Vasculopathy from Indocyanine Green Angiography Using Spatial and Temporal Patterns.

Wei-Yang Lin1, Sheng-Chang Yang1, Shih-Jen Chen2, Chia-Ling Tsai3, Shuo-Zhao Du1, Tock-Han Lim4.   

Abstract

PURPOSE: To develop a computer-aided diagnostic tool for automated detection and quantification of polypoidal regions in indocyanine green angiography (ICGA) images.
METHODS: The ICGA sequences of 59 polypoidal choroidal vasculopathy (PCV) treatment-naïve patients from five Asian countries (Hong Kong, Singapore, South Korea, Taiwan, and Thailand) were provided by the EVEREST study. The ground truth was provided by the reading center for the presence of polypoidal regions. The proposed detection algorithm used both temporal and spatial features to characterize the severity of polypoidal lesions in ICGA sequences. Leave-one-out cross validation was carried out so that each patient was used once as the validation sample. For each patient, a fixed detection threshold of 0.5 on the severity was applied to obtain sensitivity, specificity, and balanced accuracy with respect to the ground truth.
RESULTS: Our system achieved an average accuracy of 0.9126 (sensitivity = 0.9125, specificity = 0.9127) for detection of polyps in the 59 ICGA sequences. Among the total of 222 features extracted from ICGA sequence, the spatial variances exhibited best discriminative power in distinguishing between polyp and nonpolyp regions. The results also indicated the importance of combining spatial and temporal features to further improve detection accuracy.
CONCLUSIONS: The developed software provided a means of detecting and quantifying polypoidal regions in ICGA images for the first time. TRANSLATIONAL RELEVANCE: This preliminary study demonstrated a computer-aided diagnostic tool, which enables objective evaluation of PCV and its progression. Ophthalmologists can easily visualize the polypoidal regions and obtain quantitative information about polyps by using the proposed system.

Entities:  

Keywords:  Polypoidal choroidal vasculopathy; computer-aided diagnostic tool; indocyanine green angiography

Year:  2015        PMID: 25806144      PMCID: PMC4364496          DOI: 10.1167/tvst.4.2.7

Source DB:  PubMed          Journal:  Transl Vis Sci Technol        ISSN: 2164-2591            Impact factor:   3.283


  12 in total

1.  The origins of polypoidal choroidal vasculopathy.

Authors:  M Yuzawa; R Mori; A Kawamura
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

2.  Automatic characterization of classic choroidal neovascularization by using AdaBoost for supervised learning.

Authors:  Chia-Ling Tsai; Yi-Lun Yang; Shih-Jen Chen; Kai-Shung Lin; Chih-Hao Chan; Wei-Yang Lin
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-25       Impact factor: 4.799

3.  EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy.

Authors:  Adrian Koh; Won Ki Lee; Lee-Jen Chen; Shih-Jen Chen; Yehia Hashad; Hakyoung Kim; Timothy Y Lai; Stefan Pilz; Paisan Ruamviboonsuk; Erika Tokaji; Annemarie Weisberger; Tock H Lim
Journal:  Retina       Date:  2012-09       Impact factor: 4.256

4.  Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment.

Authors:  Adrian H C Koh; Lee-Jen Chen; Shih-Jen Chen; Youxin Chen; Anantharam Giridhar; Tomohiro Iida; Hakyoung Kim; Timothy Yuk Yau Lai; Won Ki Lee; Xiaoxin Li; Tock Han Lim; Paisan Ruamviboonsuk; Tarun Sharma; Shibo Tang; Mitsuko Yuzawa
Journal:  Retina       Date:  2013-04       Impact factor: 4.256

5.  Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin.

Authors:  Rufino M Silva; João Figueira; M Luz Cachulo; Liliane Duarte; José R Faria de Abreu; J G Cunha-Vaz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

6.  Photodynamic therapy with verteporfin in polypoidal choroidal vasculopathy: results after 3 years of follow-up.

Authors:  Sérgio Leal; Rufino Silva; João Figueira; M Luz Cachulo; Isabel Pires; José Rui Faria de Abreu; José Guilherme Cunha-Vaz
Journal:  Retina       Date:  2010-09       Impact factor: 4.256

7.  Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy.

Authors:  L A Yannuzzi; K B Freund; M Goldbaum; B Scassellati-Sforzolini; D R Guyer; R F Spaide; D Maberley; D W Wong; J S Slakter; J A Sorenson; Y L Fisher; D A Orlock
Journal:  Ophthalmology       Date:  2000-04       Impact factor: 12.079

8.  Polypoidal choroidal vasculopathy: an angiographic discussion.

Authors:  T H Lim; A Laude; C S H Tan
Journal:  Eye (Lond)       Date:  2010-01-15       Impact factor: 3.775

9.  Polypoidal choroidal vasculopathy in Taiwanese patients.

Authors:  Yo-Chen Chang; Wen-Chuan Wu
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2009 Nov-Dec

10.  Polypoidal choroidal vasculopathy and late geographic hyperfluorescence on indocyanine green angiography.

Authors:  S W Kang; S E Chung; W J Shin; J-H Lee
Journal:  Br J Ophthalmol       Date:  2009-03-19       Impact factor: 4.638

View more
  3 in total

1.  [Uniform classification of the pachychoroid spectrum disorders].

Authors:  Alaa Din Abdin; Shady Suffo; Fabian N Fries; Hakan Kaymak; Berthold Seitz
Journal:  Ophthalmologe       Date:  2021-04-26       Impact factor: 1.059

Review 2.  Spectrum of pachychoroid diseases.

Authors:  Sezen Akkaya
Journal:  Int Ophthalmol       Date:  2017-08-01       Impact factor: 2.031

3.  Diagnosis of Polypoidal Choroidal Vasculopathy From Fluorescein Angiography Using Deep Learning.

Authors:  Yu-Yeh Tsai; Wei-Yang Lin; Shih-Jen Chen; Paisan Ruamviboonsuk; Cheng-Ho King; Chia-Ling Tsai
Journal:  Transl Vis Sci Technol       Date:  2022-02-01       Impact factor: 3.283

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.